Covered recipient · General Payments record
ELLEN M MCVAY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$1,931.19
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $720.43 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $125.00 | 1 |
| Axsome Therapeutics, Inc. | $122.27 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $121.15 | 1 |
| Teva Pharmaceuticals USA, Inc. | $116.37 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $99.62 | 1 |
| E.R. Squibb & Sons, L.L.C. | $80.79 | 1 |
| ITI, Inc. | $19.08 | 1 |
| Abbott Laboratories | $18.37 | 1 |
| Indivior Inc. | $17.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.37 | 12/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124913560 | CMS |
| Amgen Inc. | $125.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115922473 | CMS |
| Axsome Therapeutics, Inc. | $122.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148357122 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $99.62 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117926524 | CMS |
| Boston Scientific Corporation | $121.15 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092679549 | CMS |
| E.R. Squibb & Sons, L.L.C. | $80.79 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101270199 | CMS |
| Indivior Inc. | $17.78 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144562945 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.08 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143547885 | CMS |
| Teva Pharmaceuticals USA, Inc. | $116.37 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151685361 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.